Active ingredientBromantaneCat. No. P-B113-001CAS 87913-26-6Family · Pharmaceutical analytical standards
Bromantane
An adamantane derivative developed in the 1980s at the Zakusov State Institute of Pharmacology in Moscow, with stimulant and anxiolytic effects; in Russia it has been approved since the late 2000s for neurasthenia. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Rather than acting directly on receptors, it increases dopamine production by 'switching on' the genes of the enzymes that make it; it is sometimes described as a synthetic adaptogen.
Go to the active ingredient →Active ingredientBromantaneCat. No. P-B113-001CAS 87913-26-6
Isotopically labelled6-Hydroxy Bromantane-d5Cat. No. P-B113-002CAS 1794941-97-1
Isotopically labelledBromantane-d5Cat. No. P-B113-004CAS 1794737-27-1
Impurity5-Hydroxy BromantaneCat. No. P-B113-006CAS 560070-28-2
Impurity6-Hydroxy BromantaneCat. No. P-B113-007CAS 1007310-57-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.